Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Zemmour

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Annals of Intensive Care|May 9, 2019
Impact of a computer-assisted decision support system (CDSS) on nutrition management in critically ill hematology patients: the NUTCHOCO study (nutritional care in hematology oncologic patients and critical outcome)Florence Ettori, Aurélia Henin, Christophe Zemmour, et al.
Gynecologic Oncology|December 23, 2019
Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomyLeonel Varela Cagetti, Christophe Zemmour, Mathieu Minsat, et al.
Clinical Genitourinary Cancer|April 14, 2021
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PETGwenaelle Gravis, Aurélie Autret, Morgane Guibert-Broudic, et al.
Brachytherapy|September 14, 2019
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancersLeonel Varela Cagetti, Christophe Zemmour, Naji Salem, et al.
Brachytherapy|August 1, 2018
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancerPierre Annede, Hugues Mailleux, Patrick Sfumato, et al.
Gynecologic Oncology|February 10, 2021
The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancerLeonel Varela Cagetti, Laurence Gonzague-Casabianca, Christophe Zemmour, et al.
Oncotarget|October 15, 2017
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory <i>versus</i> locally advanced breast cancersAudrey Monneur, Anthony Goncalves, Marine Gilabert, et al.
Brachytherapy|May 7, 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatmentsLeonel Varela Cagetti, Laurence Moureau-Zabotto, Christophe Zemmour, et al.
BMC Cancer|October 17, 2006
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancersAnne Letessier, Fabrice Sircoulomb, Christophe Ginestier, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 29, 2023
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French CenterJean-Philippe Ratone, Clément Archimbaud, Alexey Solovyev, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Annals of Intensive Care|May 9, 2019
Impact of a computer-assisted decision support system (CDSS) on nutrition management in critically ill hematology patients: the NUTCHOCO study (nutritional care in hematology oncologic patients and critical outcome)Florence Ettori, Aurélia Henin, Christophe Zemmour, et al.
Gynecologic Oncology|December 23, 2019
Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomyLeonel Varela Cagetti, Christophe Zemmour, Mathieu Minsat, et al.
Clinical Genitourinary Cancer|April 14, 2021
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PETGwenaelle Gravis, Aurélie Autret, Morgane Guibert-Broudic, et al.
Brachytherapy|September 14, 2019
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancersLeonel Varela Cagetti, Christophe Zemmour, Naji Salem, et al.
Brachytherapy|August 1, 2018
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancerPierre Annede, Hugues Mailleux, Patrick Sfumato, et al.
Gynecologic Oncology|February 10, 2021
The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancerLeonel Varela Cagetti, Laurence Gonzague-Casabianca, Christophe Zemmour, et al.
Oncotarget|October 15, 2017
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory <i>versus</i> locally advanced breast cancersAudrey Monneur, Anthony Goncalves, Marine Gilabert, et al.
Brachytherapy|May 7, 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatmentsLeonel Varela Cagetti, Laurence Moureau-Zabotto, Christophe Zemmour, et al.
BMC Cancer|October 17, 2006
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancersAnne Letessier, Fabrice Sircoulomb, Christophe Ginestier, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 29, 2023
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French CenterJean-Philippe Ratone, Clément Archimbaud, Alexey Solovyev, et al.
Pageof 5